Table III.
Peak no. | Compound | Probable activity | Probable inactivity | Predicted biological activity |
---|---|---|---|---|
1 | Gallic acid | 0.828 | 0.005 | Anti-infective |
3 | Pedunculagin (bis HHDP-hexose) | 0.918 | 0.005 | Antineoplastic |
0.860 | 0.005 | Apoptosis agonist | ||
0.817 | 0.006 | Cytostatic | ||
0.898 | 0.005 | TP53 expression enhancer | ||
4 | Protocatechuic acid | 0.776 | 0.005 | Anti-infective |
0.834 | 0.003 | Antimutagenic | ||
0.906 | 0.003 | Antiseptic | ||
8 | Epigallocatechin | 0.815 | 0.005 | Anticarcinogenic |
0.953 | 0.001 | Antimutagenic | ||
0.742 | 0.019 | Antineoplastic | ||
0.712 | 0.005 | Antiviral (Influenza) | ||
0.759 | 0.010 | Apoptosis agonist | ||
0.710 | 0.005 | Proliferative diseases treatment | ||
0.963 | 0.003 | TP53 expression enhancer | ||
9 | Vanillic acid | 0.708 | 0.007 | Anti-infective |
0.834 | 0.003 | Antimutagenic | ||
0.898 | 0.003 | Antiseptic | ||
0.713 | 0.024 | TP53 expression enhancer | ||
10 | P-coumaric acid hexoside | 0.887 | 0.003 | Anticarcinogenic |
0.875 | 0.004 | Anti-infective | ||
0.759 | 0.017 | Antineoplastic | ||
0.751 | 0.004 | Antiviral (Influenza) | ||
0.813 | 0.005 | Caspase 3 stimulant | ||
0.744 | 0.005 | Cell adhesion molecule inhibitor | ||
0.955 | 0.002 | G-protein-coupled receptor kinase inhibitor | ||
0.811 | 0.003 | Proliferative diseases treatment | ||
0.828 | 0.009 | TP53 expression enhancer | ||
11 | Catechin | 0.795 | 0.005 | Anticarcinogenic |
0.959 | 0.003 | TP53 expression enhancer | ||
13 | Epicatechin | 0.795 | 0.005 | Anticarcinogenic |
0.959 | 0.003 | TP53 expression enhancer | ||
17 | Epigallocatechingallate | 0.841 | 0.004 | Anticarcinogenic |
0.926 | 0.002 | Antimutagenic | ||
0.771 | 0.003 | Antiviral (Influenza) | ||
0.741 | 0.012 | Apoptosis agonist | ||
0.937 | 0.004 | TP53 expression enhancer | ||
23 | Quercetin 3-O-glucoside | 0.965 | 0.001 | Anticarcinogenic |
0.714 | 0.009 | Antifungal | ||
0.726 | 0.006 | Anti-infective | ||
0.763 | 0.004 | Antimutagenic | ||
0.833 | 0.008 | Antineoplastic | ||
0.715 | 0.005 | Antiviral (Influenza) | ||
0.792 | 0.009 | Apoptosis agonist | ||
0.801 | 0.005 | Caspase 3 stimulant | ||
0.825 | 0.006 | Cytostatic | ||
0.921 | 0.002 | Proliferative diseases treatment | ||
0.959 | 0.003 | TP53 expression enhancer | ||
26 | Quercetin 3-O-rhamnoside (quercitrin) | 0.943 | 0.002 | Anticarcinogenic |
0.740 | 0.008 | Antifungal | ||
0.748 | 0.005 | Antimutagenic | ||
0.854 | 0.007 | Antineoplastic | ||
0.814 | 0.007 | Apoptosis agonist | ||
0.803 | 0.005 | Caspase 3 stimulant | ||
0.751 | 0.008 | Cytostatic | ||
0.890 | 0.002 | Proliferative diseases treatment | ||
0.928 | 0.004 | TP53 expression enhancer | ||
30 | Tellimagrandin I (digalloyl-HHDP-hexose) | 0.706 | 0.007 | Anti-infective |
0.790 | 0.012 | TP53 expression enhancer |
Only activities with probable activity >0.700 and PubChem available compounds are shown. HHDP, hexahydroxydiphenol.